BioAge - Rasio total nilai perusahaan marang pendapatan BIOA

Logo perusahaan publik bioagelabs.com (BIOA)

BioAge Labs, Inc. (BIOA) is a longevity innovator with a robust analytical foundation that has earned expert recognition. The EV/Sales trajectory illustrates the current market valuation, where -7494.19 indicates the level of this metric. Steady demand for metabolic disorder treatments creates long-term growth potential, while the recruitment of leading data scientists following the IPO ensures the development of cutting-edge R&D competencies.

BIOA BioAge Labs, Inc.: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

BioAge Labs, Inc - rincian analitis lan metrik utama (BIOA)

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:BIOA, BioAge Labs, Inc.
Barang unggulan BioAge Labs Inc.

The investment attractiveness of BioAge Labs, Inc. (BIOA) is driven by the potential of its therapies for metabolic disorders and aging. This metric compares the total enterprise value, including net debt, against the volume of generated sales. By analyzing the company's EV/Sales valuation, an investor can determine the market value of one dollar of revenue regardless of leverage. In the biopharmaceutical sector, this indicator reflects expectations for future insurance reimbursements. This chart confirms the effective capitalization of intellectual assets.

Analisis pesaing BioAge Labs, Inc.

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Sagimet - Koefisien nilai perusahaan marang pendapatan|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)